HBSXNBM(SH:600293)2020-10-27 16:00Financial Performance - Operating revenue for the first nine months was CNY 1,933,193,629.30, down 30.08% year-on-year[7] - Net profit attributable to shareholders was a loss of CNY 597,168,584.09, a decrease of 1,214.06% compared to the same period last year[7] - Basic and diluted earnings per share were both -CNY 0.51, a decrease of 1,120.00% year-on-year[8] - The weighted average return on equity was -16.30%, a decrease of 17.86 percentage points compared to the previous year[8] - The company expects a cumulative net profit loss for the year due to the impact of COVID-19 and asset impairment provisions[17] Cash Flow - Cash flow from operating activities decreased by 47.10% to CNY 57,948,381.46 for the first nine months[7] - Cash received from sales decreased by 47.30% to RMB 1,515,884,390.58 compared to RMB 2,876,539,936.22 in the previous year[16] - The net cash flow from operating activities for the first three quarters of 2020 was ¥57.95 million, down from ¥109.54 million in the same period of 2019, a decrease of 47.3%[34] - The cash inflow from operating activities totaled ¥1.83 billion in the first three quarters of 2020, down from ¥3.22 billion in the same period of 2019, a decrease of 43.3%[34] - The company incurred a total cash outflow of 513,594,731.09 RMB from operating activities, a decrease from 815,450,731.21 RMB in the previous year, representing a reduction of about 37.1%[37] Assets and Liabilities - Total assets decreased by 9.89% to CNY 6,189,920,936.65 compared to the end of the previous year[7] - Non-current assets totaled CNY 3,547,069,679.15 in Q3 2020, down from CNY 4,034,097,631.39 in 2019, representing a decrease of approximately 12.1%[21] - The company's total liabilities decreased from CNY 2,845,988,485.52 in 2019 to CNY 2,750,332,188.24 in Q3 2020, a decline of around 3.4%[22] - Shareholders' equity decreased from CNY 4,022,939,802.79 in 2019 to CNY 3,439,588,748.41 in Q3 2020, a drop of approximately 14.5%[23] - Current liabilities decreased from CNY 2,645,567,150.45 in 2019 to CNY 2,556,524,606.77 in Q3 2020, a reduction of about 3.4%[22] Inventory and Expenses - Inventory increased by 30.25% to RMB 423,015,107.38 from RMB 324,779,216.58 due to an increase in stock and raw materials[16] - The company's research and development expenses rose by 43.96% to RMB 24,360,285.93, reflecting increased investment in product development[16] - Research and development expenses for Q3 2020 were ¥9,716,230.11, compared to ¥7,249,226.78 in Q3 2019, marking an increase of 34.1%[26] - The company incurred financial expenses of ¥7.08 million in Q3 2020, down from ¥11.67 million in Q3 2019, a reduction of 39.5%[31] Shareholder Information - The total number of shareholders at the end of the reporting period was 42,442[12] - The largest shareholder, Xu Xizhong, held 17.88% of the shares, which are currently frozen[12] Market and Future Outlook - The company has not disclosed any new product developments or market expansion strategies in this report[5] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[26]